Efalex Improves Social Responses and Attention in Children and Adolescents with Autism

Objective: To determine the efficacy and safety of Efalex to reduce symptoms of autism and to determine the relationship between blood fatty acid status and treatment response.

Assessments:

  • Social Responsiveness Sacle – Parent (SRS-P)– Assesses social awareness, cognition, comunication, motivation, autistic mannerisms and added scores provide a total score.
  • Child Behaviour Checklist (CBCL) – Measures anxious/depressed symptoms, with-drawn/depressed symptoms, somatic problems, social problems, thought problems, attention problems, rule-breaking behaviours, agressive behaviours.
  • Blood Fatty Acid Composition Ratio of AA:EPA, Ratio of Omega-3 long chain polyunsaturated fatty acids (LC-PUFAs): Total LC-PUFAs, EPA and DHA

Conclusion: Efalex can safely and effectively reduce autism symptoms

Download Research Paper

image2

Subscribe to our mailing list

* indicates required